UBQLN2 and amyotrophic lateral sclerosis: Thus, the UBQLN2-P497H iPSC line and its isogenic control iPSC line provide an unlimited number of affected neurons in patients theoretically, and increase the number of opportunities for mechanism research and drug screening of UBQLN2-P497H mutation-related ALS.